Utility of echocardiographic measurement in assessing pulmonary arterial hypertension (PH) in COPD and correlation with severity and potential risk of acute exacerbation within 30 days
O. Asma (Sousse, Tunisia), A. Sana (Sousse, Tunisia), B. Wafa (Sousse, Tunisia), K. Asma (Sousse, Tunisia), B. Rahma (Kairouan, Tunisia), K. Amani (Kairouan, Tunisia), G. Imene (Sousse, Tunisia), A. Ahmed (Sousse, Tunisia), H. Abdelaziz (Sousse, Tunisia)
Source: International Congress 2022 – Exacerbations in COPD: biomarkers and management
Session: Exacerbations in COPD: biomarkers and management
Session type: Thematic Poster
Number: 205
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O. Asma (Sousse, Tunisia), A. Sana (Sousse, Tunisia), B. Wafa (Sousse, Tunisia), K. Asma (Sousse, Tunisia), B. Rahma (Kairouan, Tunisia), K. Amani (Kairouan, Tunisia), G. Imene (Sousse, Tunisia), A. Ahmed (Sousse, Tunisia), H. Abdelaziz (Sousse, Tunisia). Utility of echocardiographic measurement in assessing pulmonary arterial hypertension (PH) in COPD and correlation with severity and potential risk of acute exacerbation within 30 days. 205
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|